RecallRadar

FDA Drug recall D-1067-2013

Venlafaxine (Venlafaxine Hydrochloride) extended release Tablets, 225 mg, packaged in a) 30- count bottle (NDC 0131-3268-32) and b) 90-coun…

On 2013-10-09 the FDA classified a Class III recall of Venlafaxine (Venlafaxine Hydrochloride) extended release Tablets, 225 mg, packaged in a) 30- count bottle (NDC 0131-3268-32) and b) 90-coun… by Osmotica Pharmaceutical, citing failed Dissolution Specification:12 hour time point at 18 months of product shelf life.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1067-2013
ClassificationClass III
Statusterminated
Initiated2013-09-16
Published2013-10-09
Last updated2026-09-13 11:51 UTC
CompanyOsmotica Pharmaceutical
DistributionUS

Product

Venlafaxine (Venlafaxine Hydrochloride) extended release Tablets, 225 mg, packaged in a) 30- count bottle (NDC 0131-3268-32) and b) 90-count bottle (NDC: 0131-3268-46), Rx only, Manufactured by: Kremers Urban Pharmaceuticals Inc. For: Osmotica Pharmaceutical Corp., Wilmington, NC 28405, USA.

Reason

Failed Dissolution Specification:12 hour time point at 18 months of product shelf life.

Identifiers

code_infoLot #: a) 58975, 58976, 58977, 65165 , Exp 01/14; b) 58973, 58974, 65131, Exp: 01/14

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1067-2013%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.